Litigator of the Week Runners-Up and Shout-Outs — Hayward Holdings
Latham team honored for securing dismissal in a federal securities putative class action for client Hayward Holdings, a designer and manufacturer of pool equipment.
Kevin M. McDonough is a partner in Latham’s New York office and a member of the firm’s Securities Litigation & Professional Liability and White Collar Defense & Investigations Practices. The New York Law Journal named him “Attorney of the Year” in 2017.
Kevin specializes in securities and class action litigation, SEC and other regulatory investigations and complex commercial litigation. He represents issuers and their executives, boards of directors, accounting firms and global financial institutions in a variety of civil actions and regulatory matters. He has been recognized by The Legal 500 for his experience in litigation involving financial institutions.
Kevin is a member of Latham’s Pro Bono Committee and an active participant in the firm’s pro bono programs. He has served as pro bono counsel to the Independent Commission on New York City Criminal Justice and Incarceration Reform. Kevin also serves on the board of New York Lawyers for the Public Interest. In recognition of his dedication to pro bono work, he received the Brooklyn Volunteer Lawyers Project's 2016 Champion of Justice Award.
Kevin is co-editor of the treatise Federal Securities Litigation: Commentary and Forms, A Deskbook for the Practitioner (2d ed. 2012) and serves as a member of Law360’s Securities Editorial Board. Prior to joining Latham, Kevin served as law clerk for the Honorable Joel A. Pisano in the United States District Court for the District of New Jersey.
Kevin's experience includes representing:
Latham team honored for securing dismissal in a federal securities putative class action for client Hayward Holdings, a designer and manufacturer of pool equipment.
Latham lawyers honored for securing the dismissal of a securities fraud complaint brought against Funko and its former CEO and CFO, and for a win at the D.C. Circuit for United Therapeutics.
Latham team is recognized after winning the affirmance of the dismissal of a securities suit against Philip Morris International.